Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital
- PMID: 30355286
- PMCID: PMC6201544
- DOI: 10.1186/s12913-018-3627-3
Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital
Abstract
Background: Irrational drug use is a global health challenge in all healthcare settings, such as hospitals. This study evaluated the impact of an intervention by the pharmaceutical care unit on the use pattern of high-value medications and their direct costs in a referral hospital.
Methods: This interventional, prospective study was carried out in clinical wards of Namazi Hospital (Shiraz University of Medical Sciences) during six months from May 2015 to October 2015. Clinical pharmacists completed the checklists for albumin, intravenous (IV) pantoprazole, and IV immune globulin (IVIG), as three high-cost medications. When ordering these medications, the physicians were asked to complete the checklists. Then, trained pharmacists examined the checklists, based on the clinical and paraclinical conditions.
Results: The total number of administered medications and their relative cost decreased by 50.76% through guideline implementation; the difference was significant (P < 0.001). In addition, the direct cost of albumin and IV pantoprazole significantly decreased (55.8% and 83.92%, respectively). In contrast, the direct cost of IVIG increased by 40.9%. After guideline implementation, the monthly direct cost of all three medications decreased by $77,720 (55.88%). The all-cause in-hospital mortality rate did not change significantly due to the intervention. The median length of hospital stay was six and seven days, respectively in the pre- and post-intervention periods.
Conclusion: Based on the findings, implementation of guidelines by the pharmaceutical care unit caused a significant reduction in albumin and IV pantoprazole consumption and reduced their direct costs in a referral center in Iran.
Keywords: Albumin; Direct cost; Guideline implementation; Intravenous immune globulin; Intravenous pantoprazole; Pharmaceutical care unit.
Conflict of interest statement
Ethics approval and consent to participate
The Institutional Review Board and the Medical Ethics Committee of the Shiraz University of Medical Sciences approved the study and written informed consent form was received from patients or their family members to participate into the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Implementation of Pharmaceutical Practice Guidelines by a Project Model Based: Clinical and Economic Impact.Medicine (Baltimore). 2015 Oct;94(42):e1744. doi: 10.1097/MD.0000000000001744. Medicine (Baltimore). 2015. PMID: 26496288 Free PMC article.
-
Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing.Pharmacotherapy. 2001 Feb;21(2):129-41. doi: 10.1592/phco.21.2.129.34105. Pharmacotherapy. 2001. PMID: 11213848
-
Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.Pharm World Sci. 2010 Dec;32(6):707-10. doi: 10.1007/s11096-010-9451-4. Epub 2010 Nov 4. Pharm World Sci. 2010. PMID: 21052835
-
Prospective application of the interdisciplinary bedside rounding checklist 'TEMP' is associated with reduced infections and length of hospital stay.BMJ Open Qual. 2022 Dec;11(4):e002045. doi: 10.1136/bmjoq-2022-002045. BMJ Open Qual. 2022. PMID: 36588303 Free PMC article. Review.
-
Expert opinion regarding clinical and other outcome considerations in the formulary review of immune globulin.J Manag Care Pharm. 2007 Apr;13(3):278-83. doi: 10.18553/jmcp.2007.13.3.278. J Manag Care Pharm. 2007. PMID: 17407395 Free PMC article. No abstract available.
Cited by
-
Drug Utilization Evaluation of Erythropoietin at a Referral Teaching Hospital in Iran.Adv Pharmacol Pharm Sci. 2023 Nov 7;2023:6685602. doi: 10.1155/2023/6685602. eCollection 2023. Adv Pharmacol Pharm Sci. 2023. PMID: 38029231 Free PMC article.
-
Evaluation of factors that influenced the length of hospital stay using data mining techniques.BMC Med Inform Decis Mak. 2022 Oct 29;22(1):280. doi: 10.1186/s12911-022-02027-w. BMC Med Inform Decis Mak. 2022. PMID: 36309751 Free PMC article.
-
Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020.BMC Public Health. 2023 Jul 17;23(1):1364. doi: 10.1186/s12889-023-16199-1. BMC Public Health. 2023. PMID: 37461105 Free PMC article. Review.
-
Practical Concerns about the Metrics and Methods of Financial Outcome Measurement in Antimicrobial Stewardship Programs: A Narrative Review.Iran J Med Sci. 2022 Sep;47(5):394-405. doi: 10.30476/ijms.2021.92213.2343. Iran J Med Sci. 2022. PMID: 36117584 Free PMC article. Review.
-
Clinical and economic impacts of clinical pharmacists' interventions in Iran: a systematic review.Daru. 2019 Jun;27(1):361-378. doi: 10.1007/s40199-019-00245-8. Epub 2019 Jan 23. Daru. 2019. PMID: 30674033 Free PMC article.
References
-
- Holloway K, Green T. Drug and therapeutics committees: a practical guide: World Health Organization; 2003. Available at: http://apps.who.int/medicinedocs/en/d/Js4882e/. Accessed 27 March 2017
MeSH terms
Substances
LinkOut - more resources
Full Text Sources